Buckyballs Make Fantastic Voyage: “‘The lethal dose in animals is astronomical,’ Sagman said. ‘And it is absorbed well orally and excreted unaltered by the kidneys, so it doesn’t harm target organs. That’s important because compliance is a big problem with AIDS drugs, since patients find them too toxic.’ The second fullerene drug, which the company hopes to put into clinical trials, fights Lou Gehrig’s disease. If successful, it may treat similar illnesses such Parkinson’s disease.”